In a subset of patients the hormone leptin can be leveraged as a therapeutic agent to move fat out of the liver.

A liver specialist discusses improvements to the quality of care delivered to individuals with this condition. 

A hepatologist comments on the new USPSTF guidelines for detecting hepatitis B in non-pregnant adults and adolescents. 

A recent paper from two U-M hepatologists highlights the liver dangers associated with consuming some herbal and dietary supplements designed to build muscle or lose weight.

A cutting-edge imaging strategy could significantly improve survival rates among patients at risk for liver cancer.

Hepatitis C rates have surged in the U.S. as drug use and opioid abuse have risen. A Michigan Medicine hepatologist reflects on the troubling trend.